NCT03963336View on ClinicalTrials.gov

Quantitative D-dimer Level and Anticoagulant Therapy in Idiopathic Intracranial Hypertension

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 22, 2017

Primary Completion Date

July 23, 2018

Study Completion Date

August 2, 2018

Conditions
Idiopathic Intracranial Hypertension
Interventions
DRUG

LMWH

Subcutaneous LMWH 1mg/kg/day for 2 weeks

DRUG

acetazolamide

Carbonic anhydrase inhibitor 1-2g/day for 6 months

Trial Locations (1)

63611

Fayoum University Hospital, Al Fayyum

All Listed Sponsors
lead

Fayoum University

OTHER

NCT03963336 - Quantitative D-dimer Level and Anticoagulant Therapy in Idiopathic Intracranial Hypertension | Biotech Hunter | Biotech Hunter